ArriVent BioPharma Common Stock Statistics Share Statistics ArriVent BioPharma Common Stock has 40.57M
shares outstanding. The number of shares has increased by 1.87%
in one year.
Shares Outstanding 40.57M Shares Change (YoY) 1.87% Shares Change (QoQ) 0.58% Owned by Institutions (%) 85.8% Shares Floating 21.6M Failed to Deliver (FTD) Shares 50 FTD / Avg. Volume 0.01%
Short Selling Information The latest short interest is 6.7M, so 16.52% of the outstanding
shares have been sold short.
Short Interest 6.7M Short % of Shares Out 16.52% Short % of Float 22.08% Short Ratio (days to cover) 19.23
Valuation Ratios The PE ratio is -10.42 and the forward
PE ratio is -5.45.
ArriVent BioPharma Common Stock's PEG ratio is
-0.58.
PE Ratio -10.42 Forward PE -5.45 PS Ratio 0 Forward PS 302.6 PB Ratio 3.25 P/FCF Ratio -11.94 PEG Ratio -0.58
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for ArriVent BioPharma Common Stock.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 13.14,
with a Debt / Equity ratio of 0.
Current Ratio 13.14 Quick Ratio 13.14 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.55M Employee Count 52 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -26.62% in the
last 52 weeks. The beta is 1.18, so ArriVent BioPharma Common Stock's
price volatility has been higher than the market average.
Beta 1.18 52-Week Price Change -26.62% 50-Day Moving Average 20.25 200-Day Moving Average 22.79 Relative Strength Index (RSI) 49.7 Average Volume (20 Days) 340,814
Income Statement
Revenue n/a Gross Profit n/a Operating Income -94.31M Net Income -80.49M EBITDA -80.49M EBIT -80.49M Earnings Per Share (EPS) -2.56
Full Income Statement Balance Sheet The company has 74.29M in cash and 176K in
debt, giving a net cash position of 74.12M.
Cash & Cash Equivalents 74.29M Total Debt 176K Net Cash 74.12M Retained Earnings -238.33M Total Assets 269.51M Working Capital 230.51M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -70.21M
and capital expenditures 0, giving a free cash flow of -70.21M.
Operating Cash Flow -70.21M Capital Expenditures n/a Free Cash Flow -70.21M FCF Per Share -2.23
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
